...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Replicated studies of two randomized trials of angiotensin-converting enzyme inhibitors: further empiric validation of the 'prior event rate ratio' to adjust for unmeasured confounding by indication.
【24h】

Replicated studies of two randomized trials of angiotensin-converting enzyme inhibitors: further empiric validation of the 'prior event rate ratio' to adjust for unmeasured confounding by indication.

机译:两项关于血管紧张素转化酶抑制剂的随机试验的重复研究:进一步经验性验证“先验事件发生率比”以适应因适应症引起的未测混杂。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: Using data from the United Kingdom General Practice Research Database (GPRD) randomized controlled trials (RCTs) were replicated to determine whether identifiable study characteristics and/or analytic methods influence the validity of observational studies. METHODS: This study reports GPRD replications of 2 RCTs that investigated whether angiotensin-converting enzyme inhibitors (ACEIs) improve cardiovascular outcomes in patients without congestive heart failure at high risk for cardiovascular disease (heart outcomes prevention evaluation (HOPE) and EUROPA). The GPRD studies replicated to the extent feasible all aspects of these RCTs except for randomization. RESULTS: With adjustment for confounders using conventional biostatistical techniques, both GPRD studies exhibited results divergent from the RCTs. Myocardial infarction, stroke, congestive heart failure, and coronary revascularization were increased in the Exposed group of both GPRD studies; whereas these outcomes either were decreased orunchanged by ACEI therapy in both RCTs. The results also were analyzed with a new method that appears to adjust for both identified and unmeasured confounders. With this methodology that employs the ratio of event rates between the Exposed and Unexposed cohorts prior to study start time to adjust the study hazard ratio (HR), the GPRD results for myocardial infarction, stroke, and coronary revascularization were largely similar to those found in the two RCTs. CONCLUSIONS: This study provides additional empiric evidence suggesting that this new analytic methodology, 'prior events rate ratio (PERR)' adjustment, is a promising solution for the vexing problem of 'unmeasured confounding' in observational studies. Additional statistical simulations are needed to fully appreciate the applicability and limitations of this method.
机译:目的:使用来自英国通用实践研究数据库(GPRD)的数据进行重复随机对照试验(RCT),以确定可识别的研究特征和/或分析方法是否影响观察性研究的有效性。方法:本研究报告了2项RCT的GPRD复制,研究了血管紧张素转换酶抑制剂(ACEIs)是否可改善无充血性心力衰竭的高心血管疾病风险患者的心血管结局(心脏结局预防评估(HOPE)和EUROPA)。 GPRD研究在尽可能随机的条件下复制了这些RCT的所有方面。结果:通过使用常规生物统计学技术对混杂因素进行调整,两项GPRD研究均显示出与RCT不同的结果。两项GPRD研究的暴露组均增加了心肌梗塞,中风,充血性心力衰竭和冠脉血运重建。而在两个随机对照试验中,ACEI疗法可降低或保持这些结果。还使用一种新方法对结果进行了分析,该新方法似乎可以针对已识别和未测量的混杂因素进行调整。通过这种方法,在研究开始时间之前采用暴露人群和未暴露人群之间的事件发生率之比来调整研究危险比(HR),心肌梗死,中风和冠脉血运重建的GPRD结果与两个RCT。结论:这项研究提供了额外的经验证据,表明这种新的分析方法,即“先验事件发生率比(PERR)”调整,对于解决观察性研究中“无法衡量的混淆”这一棘手的问题是一个很有前途的解决方案。需要额外的统计模拟以充分了解此方法的适用性和局限性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号